BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38132384)

  • 1. Quantitative Analysis of Prostate MRI: Correlation between Contrast-Enhanced Magnetic Resonance Fingerprinting and Dynamic Contrast-Enhanced MRI Parameters.
    Choi MH; Lee YJ; Han D; Kim DH
    Curr Oncol; 2023 Dec; 30(12):10299-10310. PubMed ID: 38132384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
    Lee YS; Choi MH; Lee YJ; Han D; Kim DH
    Br J Radiol; 2022 Mar; 95(1131):20210479. PubMed ID: 34415785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis.
    Gao P; Shi C; Zhao L; Zhou Q; Luo L
    Medicine (Baltimore); 2016 Dec; 95(52):e5715. PubMed ID: 28033274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T
    Sushentsev N; Kaggie JD; Buonincontri G; Schulte RF; Graves MJ; Gnanapragasam VJ; Barrett T
    Sci Rep; 2020 Nov; 10(1):20475. PubMed ID: 33235229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement degree of brain metastases: correlation analysis between enhanced T2 FLAIR and vascular permeability parameters of dynamic contrast-enhanced MRI.
    Jin T; Zhang H; Liu X; Kong X; Makamure J; Chen Z; Alwalid O; Yao Z; Wang J
    Eur Radiol; 2021 Aug; 31(8):5595-5604. PubMed ID: 33847812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.
    Afshari Mirak S; Mohammadian Bajgiran A; Sung K; Asvadi NH; Markovic D; Felker ER; Lu D; Sisk A; Reiter RE; Raman SS
    Abdom Radiol (NY); 2020 Jul; 45(7):2225-2234. PubMed ID: 31549211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D MR fingerprinting (MRF) for simultaneous T1 and T2 quantification of the bone metastasis: Initial validation in prostate cancer patients.
    Choi MH; Lee SW; Kim HG; Kim JY; Oh SW; Han D; Kim DH
    Eur J Radiol; 2021 Nov; 144():109990. PubMed ID: 34638082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.
    Baur ADJ; Schwabe J; Rogasch J; Maxeiner A; Penzkofer T; Stephan C; Rudl M; Hamm B; Jung EM; Fischer T
    Eur Radiol; 2018 May; 28(5):1949-1960. PubMed ID: 29238867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
    Vos EK; Litjens GJ; Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ; Scheenen TW
    Eur Urol; 2013 Sep; 64(3):448-55. PubMed ID: 23751135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.
    Klawer EME; van Houdt PJ; Pos FJ; Heijmink SWTPJ; van Osch MJP; van der Heide UA
    NMR Biomed; 2018 Sep; 31(9):e3946. PubMed ID: 29974981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of dynamic
    Tau N; Berlin A; Yeung I; Halankar J; Murphy G; Jhaveri KS; Ghai S; Metser U
    Br J Radiol; 2019 Feb; 92(1094):20180568. PubMed ID: 30383459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
    Ziayee F; Müller-Lutz A; Gross J; Quentin M; Ullrich T; Heusch P; Arsov C; Rabenalt R; Albers P; Antoch G; Wittsack HJ; Schimmöller L
    Magn Reson Imaging; 2018 Nov; 53():28-33. PubMed ID: 29902565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra- and inter-observer variability in dependence of T1-time correction for common dynamic contrast enhanced MRI parameters in prostate cancer patients.
    Daniel M; Polanec SH; Wengert G; Clauser P; Pinker K; Helbich TH; Georg D; Baltzer PAT
    Eur J Radiol; 2019 Jul; 116():27-33. PubMed ID: 31153570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance fingerprinting based comprehensive quantification of T1 and T2 values of the background prostatic peripheral zone: Correlation with clinical and demographic features.
    de Oliveira Correia ET; Qiao PL; Griswold MA; Chen Y; Bittencourt LK
    Eur J Radiol; 2023 Jul; 164():110883. PubMed ID: 37209463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.
    Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M
    Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
    Shiradkar R; Panda A; Leo P; Janowczyk A; Farre X; Janaki N; Li L; Pahwa S; Mahran A; Buzzy C; Fu P; Elliott R; MacLennan G; Ponsky L; Gulani V; Madabhushi A
    Eur Radiol; 2021 Mar; 31(3):1336-1346. PubMed ID: 32876839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.
    Peled S; Vangel M; Kikinis R; Tempany CM; Fennessy FM; Fedorov A
    Acad Radiol; 2019 Sep; 26(9):e241-e251. PubMed ID: 30467073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.